Nebulized oil-in-water nanoemulsion mists for pulmonary delivery: Development, physico-chemical characterization and in vitro evaluation

Drug Development and Industrial Pharmacy

Volumn 40, Issue 9, 2014, Pages 1253-1263

  Nesamony, Jerry ^a   Shah, Ishan S ^a   Kalra, Ashish ^a   Jung, Rose ^a  

^a UNIVERSITY OF TOLEDO   (United States)

Author keywords

Aerosols; Cell toxicity; Dynamic light scattering; Nanoemulsions; Self nanoemulsification; Sterility testing; Transmission electron microscopy

Indexed keywords

CREMOPHOR; DIETHYLENE GLYCOL MONOETHYL ETHER; IBUPROFEN; MACROGOL 400; NANOMATERIAL; OIL; POLYSORBATE 80; WATER; EMULSION; NANOPARTICLE; SURFACTANT;

3T3 CELL LINE; AEROSOL; ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; LIGHT SCATTERING; MOUSE; MTT ASSAY; NANOEMULSION; NEBULIZATION; NONHUMAN; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ADMINISTRATION AND DOSAGE; ANIMAL; CHEMISTRY; EMULSION; LUNG; MEDICINAL CHEMISTRY; METABOLISM; PROCEDURES; SOLUBILITY;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; EMULSIONS; IBUPROFEN; LUNG; MICE; NANOPARTICLES; NANOSTRUCTURES; NIH 3T3 CELLS; OILS; PARTICLE SIZE; SOLUBILITY; SURFACE-ACTIVE AGENTS; WATER;

EID: 84902003048     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2013.814065     Document Type: Article

References (65)

1. Li P, Hynes SR, Haefele TF, et al. Development of clinical dosage forms for a poorly water-soluble drug II: formulation and characterization of a novel solid microemulsion preconcentrate system for oral delivery of a poorly water-soluble drug. J Pharm Sci 2009;98: 1750-64.
2. Kim HJ, Yoon KA, Hahn M, et al. Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone. Drug Dev Ind Pharm 2000;26:523-9.
3. Chang RK, Shojaei AH. Effect of a lipoidic excipient on the absorption profile of compound UK 81252 in dogs after oral administration. J Pharm Pharm Sci 2004;7:8-12.
4. Hauss DJ, Fogal SE, Ficorilli JV, et al. Lipid based delivery systems for improving the bioavailability and lymphatic transport of a poorly water soluble LTB4 inhibitor. J Pharm Sci 1998;87:164-9.
5. Porter CJH, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 2007;6:231-48.
6. Rahman MA, Hussain A, Hussain MS, et al. Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS). Drug Dev Ind Pharm 2012;39: 1-19.
7. Balakrishnan P, Lee B, Oh D, et al. Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS). Eur J Pharm Biopharm 2009;72:539-45.
8. Yi T, Wan J, Xu H, Yang X. A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs. Eur J Pharm Biopharm 2008; 70:439-44.
9. Ito Y, Kusawake T, Ishida M, et al. Oral solid gentamicin preparation using emulsifier and adsorbent. J Control Release 2005;105:23-31.
10. Ito Y, Kusawake T, Prasad Y, et al. Preparation and evaluation of oral solid heparin using emulsifier and adsorbent for in vitro and in vivo studies. Int J Pharm 2006;317:114-19.
11. Abdalla A, Klein S, Mäder K. A new self-emulsifying drug delivery system (SEDDS) for poorly soluble drugs: characterization, dissolution, in vitro digestion and incorporation into solid pellets. Eur J Pharm Sci 2008;35:457-64.
12. Setthacheewakul S, Mahattanadul S, Padoongsombat N, et al. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats. Eur J Pharm Biopharm 2010;76:75-85.
13. Chambin O, Jannin V, Champion D, et al. Influence of cryogenic grinding on properties of a self-emulsifying formulation. Int J Pharm 2004;278:79-89.
14. Ballester M, Nembrini C, Dhar N, et al. Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis. Vaccine 2011;29:6959-66. PubMed PMID: 2011:1127334. English.
15. Alhanout K, Brunel JM, Dubus JC, et al. Suitability of a new antimicrobial aminosterol formulation for aerosol delivery in cystic fibrosis. J Antimicrob Chemother 2011;66:2797-800. PubMed PMID: 2011:1507369. English.
16. Tronde A, Norden B, Marchner H, et al. Pulmonary absorption rate and bioavailability of drugs in vivo in rats: structure - absorption relationships and physicochemical profiling of inhaled drugs. J Pharm Sci 2003;92:1216-33. PubMed PMID: 2003:466128. English.
17. DeFronzo Ralph A, Bergenstal Richard M, Cefalu William T, et al. Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial. Diabetes care 2005;28:1922-8. PubMed PMID: 2005385110. English.
18. Bitonti AJ, Dumont JA, Low SC, et al. Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway. Proc Nat Acad Sci USA 2004; 101:9763-8. PubMed PMID: 2004:582254. English.
19. Wang Y, Sun J, Zhang T, et al. Enhanced oral bioavailability of tacrolimus in rats by self-microemulsifying drug delivery systems. Drug Dev Ind Pharm 2011;37:1225-30. PubMed PMID: 2011:1117551. English.
20. Craig D, Lievens H, Pitt K, Storey D. An investigation into the physico-chemical properties of self-emulsifying systems using low frequency dielectric spectroscopy, surface tension measurements and particle size analysis. Int J Pharm 1993;96:147-55.
21. Kang BK, Lee JS, Chon SK, et al. Development of selfmicroemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 2004;274:65-73.
22. Rasenack N, Muller BW. Ibuprofen crystals with optimized properties. Int J Pharm 2002;245:9-24.
23. Rasenack N, Muller BW. Properties of ibuprofen crystallized under various conditions: a comparative study. Drug Dev Ind Pharm 2002; 28:1077-89.
24. Patel N, Madan P, Lin S. Development and evaluation of controlled release ibuprofen matrix tablets by direct compression technique. Pharm Dev Technol 2011;16:1-11.
25. Gurvitz A, Hamilton B, Ruis H, Hartig A. Peroxisomal degradation of trans-unsaturated fatty acids in the yeast Saccharomyces cerevisiae. J Biol Chem 2001;276:895-903. PubMed PMID: 2001:60845. English.
26. Schmidts T, Dobler D, Nissing C, Runkel F. Influence of hydrophilic surfactants on the properties of multiple W/O/W emulsions. J Colloid Interf Sci 2009;338:184-92. PubMed PMID: 2009:993400. English.
27. Zidovska A, Ewert KK, Quispe J, et al. Block liposomes from curvature-stabilizing lipids: connected nanotubes, -rods, or -spheres. Langmuir 2009;25:2979-85. PubMed PMID: 2008:1200457. English.
28. Kawakami K, Yoshikawa T, Moroto Y, et al. Microemulsion formulation for enhanced absorption of poorly soluble drugs I. Prescription design. J Control Release 2002;81:65-74. PubMed PMID: 2002:318238. English.
29. Shakeel F, Baboota S, Ahuja A, et al. Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech 2007;8: E1-9. PubMed PMID: 2008015326. English.
30. Elnaggar YSR, El-Massik MA, Abdallah OY. Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization. Int J Pharm 2009;380:133-41. PubMed PMID: 2009:1092304. English.
31. Meng J, Zheng L. Application of mixture experimental design to simvastatin apparent solubility predictions in the microemulsifion formed by self-microemulsifying. Drug Dev Ind Pharm 2007;33: 927-31. PubMed PMID: 2007569721. English.
32. Hu L, Yang J, Liu W, Li L. Preparation and evaluation of ibuprofenloaded microemulsion for improvement of oral bioavailability. Drug Delivery 2011;18:90-5.
33. Sakai K, Maeda H, Yoshimori T, et al. High-throughput formulation screening system for self-microemulsifying drug delivery. Drug Dev Ind Pharm 2009;35:746-55. PubMed PMID: 2009:601538. English.
34. Ditner C, Bravo R, Imanidis G, Kuentz M. A systematic dilution study of self-microemulsifying drug delivery systems in artificial intestinal fluid using dynamic laser light backscattering. Drug Dev Ind Pharm 2009;35:199-208. PubMed PMID: 2009:95826. English.
35. Sakai K, Yoshimori T, Obata K, Maeda H. Design of selfmicroemulsifying drug delivery systems using a high-throughput formulation screening system. Drug Dev Ind Pharm 2010;36: 1245-52. PubMed PMID: 2010802927. English.
36. Wei L, Sun P, Nie S, Pan W. Preparation and evaluation of SEDDS and SMEDDS containing carvedilol. Drug Dev Ind Pharm 2005;31: 785-94. PubMed PMID: 2005:1093700. English.
37. Kawakami K, Yoshikawa T, Hayashi T, et al. Microemulsion formulation for enhanced absorption of poorly soluble drugs II. In vivo study. J Control Release 2002;81:75-82. PubMed PMID: 2002:318239. English.
38. Patel D, Sawant KK. Oral bioavailability enhancement of acyclovir by Self-Microemulsifying Drug Delivery Systems (SMEDDS). Drug Dev Ind Pharm 2007;33:1318-26. PubMed PMID: 2007:1443230. English.
39. Dixit A, Rajput S, Patel S. Preparation and bioavailability assessment of SMEDDS containing valsartan. AAPS Pharm Sci Tech 2010;11:314-21.
40. Cornaire G, Woodley J, Hermann P, et al. Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm 2004;278:119-31. PubMed PMID: 2004:417180. English.
41. Griffin Brendan T, O'Driscoll Caitriona M. A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model. J pharm pharmacol 2006;58:917-25. PubMed PMID: 2006389938. English.
42. Gershanik T, Benzeno S, Benita S. Interaction of a self-emulsifying lipid drug delivery system with the everted rat intestinal mucosa as a function of droplet size and surface charge. Pharm Res 1998;15: 863-9.
43. Gershanik T, Haltner E, Lehr CM, Benita S. Charge-dependent interaction of self-emulsifying oil formulations with Caco-2 cells monolayers: binding, effects on barrier function and cytotoxicity. Int J Pharm 2000;211:29-36.
44. Colomer A, Pinazo A, Garcia MT, et al. pH-sensitive surfactants from lysine: assessment of their cytotoxicity and environmental behavior. Langmuir 2012;28:5900-12. PubMed PMID: 2012:408444. English.
45. Nogueira DR, Mitjans M, Moran MC, et al. Membrane-destabilizing activity of pH-responsive cationic lysine-based surfactants: role of charge position and alkyl chain length. Amino Acids 2012;43: 1203-15. PubMed PMID: 2012:1198296. English.
46. Almeida JAS, Faneca H, Carvalho RA, et al. Dicationic alkylammonium bromide gemini surfactants. Membrane perturbation and skin irritation. PLoS One 2011;6:e26965. PubMed PMID: 2011:1569650. English.
47. Zhang D, Hamilton PD, Kao JLF, et al. Formation of nanogel aggregates by an amphiphilic cholesteryl-poly(amidoamine) dendrimer in aqueous media. J Polym Sci Part A: Polym Chem 2007;45: 2569-75. PubMed PMID: 2007:636704. English.
48. Sintov AC, Levy HV, Botner S. Systemic delivery of insulin via the nasal route using a new microemulsion system: in vitro and in vivo studies. J Control Release 2010;148:168-76. PubMed PMID: 2010:1445032. English.
49. Landahl HD, Herrmann RG. On the retention of air-borne particulates in the human lung. J Ind Hyg Toxicol 1948;30:181-8. PubMed PMID: 1948009667. English.
50. Adjei A, Garren J. Pulmonary delivery of peptide drugs: effect of particle size on bioavailability of leuprolide acetate in healthy male volunteers. Pharm Res 1990;7:565-9. PubMed PMID: 1990:503287. English.
51. Elversson J, Millqvist-Fureby A, Alderborn G, Elofsson U. Droplet and particle size relationship and shell thickness of inhalable lactose particles during spray drying. J Pharm Sci 2003;92:900-10. PubMed PMID: 2003:277325. English.
52. Edwards DA, Hanes J, Caponetti G, et al. Large porous particles for pulmonary drug delivery. Science 1997;276:1868-71. PubMed PMID: 1997:444500. English.
53. Tolman JA, Williams III RO. Advances in the pulmonary delivery of poorly water-soluble drugs: influence of solubilization on pharmacokinetic properties. Drug Dev Ind Pharm 2010;36:1-30. PubMed PMID: 2010:26366. English.
54. Watts AB, McConville JT, Williams III RO. Current therapies and technological advances in aqueous aerosol drug delivery. Drug Dev Ind Pharm 2008;34:913-22. PubMed PMID: 2008:1121110. English.
55. Kuentz M, Cavegn M. Critical concentrations in the dilution of oral self-microemulsifying drug delivery systems. Drug Dev Ind Pharm 2010;36:531-8. PubMed PMID: 2010:605032. English.
56. Nesamony J, Zachar CL, Jung R, et al. Preparation, characterization, sterility validation, and in vitro cell toxicity studies of microemulsions possessing potential parenteral applications. Drug Dev Ind Pharm 2013;39:240-51. PubMed PMID: 2013:84678. English.
57. Twentyman PR, Luscombe M. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Brit J Cancer 1987;56:279-85. PubMed PMID: 1988024713. English.
58. Chaurasiya A, Singh AK, Jain GK, et al. Dual approach utilizing self microemulsifying technique and novel P-gp inhibitor for effective delivery of taxanes. J Microencapsul 2012;29:583-95. PubMed PMID: 2012:1235010. English.
59. Lo J-T, Chen B-H, Lee T-M, et al. Self-emulsifying O/W formulations of paclitaxel prepared from mixed nonionic surfactants. J Pharm Sci 2010;99:2320-32. PubMed PMID: 2010:322296. English.
60. Kotyla T, Kuo F, Moolchandani V, et al. Increased bioavailability of a transdermal application of a nano-sized emulsion preparation. Int J Pharm 2008;347:144-8. PubMed PMID: 2007:1370066. English.
61. Shafiq S, Shakeel F, Talegaonkar S, et al. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm 2007;66:227-43. PubMed PMID: 2007:474252. English.
62. Nekkanti V, Karatgi P, Prabhu R, Pillai R. Solid self-microemulsifying formulation for candesartan cilexetil. AAPS Pharm Sci Tech 2010;11:9-17.
63. Ofokansi KC, Chukwu KI, Ugwuanyi SI. The use of liquid selfmicroemulsifying drug delivery systems based on peanut oil/tween 80 in the delivery of griseofulvin. Drug Dev Ind Pharm 2009;35: 185-91. PubMed PMID: 2009:95828. English.
64. Tarr BD, Yalkowsky SH. Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size. Pharm Res 1989;6:40-3. PubMed PMID: 1989:107567. English.
65. Sun M, Si L, Zhai X, et al. The influence of co-solvents on the stability and bioavailability of rapamycin formulated in selfmicroemulsifying drug delivery systems. Drug Dev Ind Pharm 2011;37:986-94. PubMed PMID: 2011:872585. English.